Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP771884.RAL75Ge5Gxb_3wS3JGYTJfx6qvteIdZdGfgres_Z1kv68130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP771884.RAL75Ge5Gxb_3wS3JGYTJfx6qvteIdZdGfgres_Z1kv68130_assertion type Assertion NP771884.RAL75Ge5Gxb_3wS3JGYTJfx6qvteIdZdGfgres_Z1kv68130_head.
- NP771884.RAL75Ge5Gxb_3wS3JGYTJfx6qvteIdZdGfgres_Z1kv68130_assertion wasGeneratedBy ECO_0000203 NP771884.RAL75Ge5Gxb_3wS3JGYTJfx6qvteIdZdGfgres_Z1kv68130_provenance.
- NP771884.RAL75Ge5Gxb_3wS3JGYTJfx6qvteIdZdGfgres_Z1kv68130_assertion wasDerivedFrom befree-20150227 NP771884.RAL75Ge5Gxb_3wS3JGYTJfx6qvteIdZdGfgres_Z1kv68130_provenance.
- NP771884.RAL75Ge5Gxb_3wS3JGYTJfx6qvteIdZdGfgres_Z1kv68130_assertion SIO_000772 15195927 NP771884.RAL75Ge5Gxb_3wS3JGYTJfx6qvteIdZdGfgres_Z1kv68130_provenance.
- NP771884.RAL75Ge5Gxb_3wS3JGYTJfx6qvteIdZdGfgres_Z1kv68130_assertion evidence source_evidence_literature NP771884.RAL75Ge5Gxb_3wS3JGYTJfx6qvteIdZdGfgres_Z1kv68130_provenance.
- NP771884.RAL75Ge5Gxb_3wS3JGYTJfx6qvteIdZdGfgres_Z1kv68130_assertion description "[One area of gene therapy that has generated much debate and controversy is the use of vascular endothelial growth factor (VEGF) for therapeutic angiogenesis for palliative intent, and for the prevention of restenosis following percutaneous revascularization in coronary and peripheral arterial disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771884.RAL75Ge5Gxb_3wS3JGYTJfx6qvteIdZdGfgres_Z1kv68130_provenance.